PGNY Progyny, Inc.

Progyny, Inc. is a medical device company, which engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools. Its services include egg freezing, IVF treatment, surrogacy, podcast, adoption, and Eeva Test. The company was founded on April 03, 2008 and is headquartered in New York, NY.

$43.94  +0.30 (0.69%)
As of 03/02/2021 15:59:52 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Mid cap
Health Care
Health Information Services
USA
USA
10/25/2019
86,633,647
796,652
$3,780,692,355
0.00%
SEC Edgar Online
10-Q
10-K
74340E103
US74340E1038
BKWD3M9

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
1,181.47
29.71
12.21
2.51%
1.03%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy